Clinical viewpoint examines coronary computed tomography plaque analysis in asymptomatic adults, highlighting unproven clinical utility for routine screening.
Key Points
To evaluate whether current clinical evidence supports using quantitative coronary computed tomography angiography (CCTA) plaque analysis as a screening tool to guide therapy in asymptomatic adults.
Examined clinical literature and evidence regarding quantitative plaque characterization using coronary computed tomography angiography (CCTA).
Assessed the value and efficacy of applying CCTA plaque metrics to guide preventive medical therapy in asymptomatic adult populations.
Current clinical evidence does not support the routine implementation of quantitative CCTA plaque analysis as a screening strategy in asymptomatic adults.
Evidence demonstrating that plaque-guided treatment strategies improve long-term clinical outcomes compared with standard risk assessment models remains lacking.